Analyst stock forecast
Whitehawk Therapeutics Forecast: $7.50 Analyst Target
WHWK has a $7.50 target, none rating and 6 analysts. As of 2026-08-23.
Direct answer
Whitehawk Therapeutics's average price target is $7.50.
The target implies +58.6% from the recorded current price, and the consensus rating is none.
The low target implies -15.4%, the high target implies +111.4%, and the range spans 126.8% of the current price.
Forecast evidence checked August 23, 2026.
Get free Whitehawk Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.73
- Average price target
- $7.50
- High price target
- $10.00
- Low price target
- $4.00
- Low target gap
- -15.4%
- Target upside
- +58.6%
- High target gap
- +111.4%
- Target range width
- 126.8%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is Whitehawk Therapeutics's average price target?
Whitehawk Therapeutics's verified average price target is $7.50. The target range is $4.00 to $10.00.
How far are Whitehawk Therapeutics's low and high targets from the recorded price?
The low target implies -15.4%, while the high target implies +111.4%.
How many analysts are included in Whitehawk Therapeutics's consensus?
The verified consensus includes 6 analysts.
How is Whitehawk Therapeutics's target upside or downside calculated?
The average target of $7.50 is divided by the recorded price of $4.73, then one is subtracted to produce +58.6%. This does not guarantee a future return.
When was Whitehawk Therapeutics's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.